Malabar Cancer Centre

Running trials

• Recruiting

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  NCT06890598· Phase 3· Source

• Active, not recruiting

  A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment

  NCT05133531· Phase 3· Source

• Active, not recruiting

  Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

  NCT04229979· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia

  NCT07052006· Phase 2· Source

• Completed

  Adjuvant Radiotherapy in Early Stage Oral Cancers

  NCT03853655· Source

Trial sites

• Malabar Cancer Center1 trial
• Malabar Cancer Center, Kerala1 trial
• Malabar Cancer Centre2 trials
• Malabar Cancer Centre - Thalassery1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Myelodysplastic syndromes7 works · 1 trials